Effects of Testosterone Supplementation on Neurobehavioral Outcomes in Special Operations Military Personnel with Multiple Mild Traumatic Brain Injury

Abstract: Objectives: To investigate differences in neurobehavioral outcomes between testosterone users and non-users in Special Operations military personnel with multiple mild TBI before and after Intensive Evaluation and Training Program (IETP) To investigate indication and benefit of testosterone supplementation in special operations military personnel with multiple mild TBI. Design: Cross-sectional study. Setting: IETP through the Polytrauma Network at the Palo Alto VA Hospital - a three week inpatient program designed to address sequelae of multiple mild TBI and other healthcare needs specifically for active duty Special Operations military personnel. Participants: 55 active duty Special Operations military personnel admitted to IETP with a diagnosis of multiple mild TBI. 6 were on testosterone supplementation at the start of the IETP program and continued it during their stay, the rest are classified as non-users. Interventions: IETP - three weeks of evaluation/treatment by physicians (PM&R +/- various consultants), physical therapy, occupational therapy, speech therapy, Neuropsychology, Rehabilitation Psychology, Headache Psychology, Recreation Therapy. Main outcome measures: Neurobehavioral Outcome Measures, specifically Neurobehavioral Symptom Inventory (NSI), General Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9 (PHQ-9), before and after IETP in testosterone supplementation users vs non-users. Results: Preliminary data suggests a difference in neurobehavioral outcome measures between testosterone users and non-users, with higher mean pre-IETP and post-IETP PHQ-9 and NSI scores and higher mean post-IETP GAD-7 scores. Mean pre-IETP GAD-7 scores were similar between testosterone users and non-users. Conclusions: Our study suggests that testosterone supplementation correlates to worse neurobehavioral outcome scores in active duty Special Operations military personnel, specifically the NSI and PHQ-9, despite improvements in outcome scores during IETP. This study raises speculation that benefits of testosterone supplementation may not outweigh harms/risks. Neuroendocrine dysfunction including hypogonadism is a known complication of mild TBI; the observed correlation found in our study may be explained by increased symptom burden in this subgroup diagnosed with hypogonadism. Further study is needed with larger numbers - the IETP population can provide a suitable population for continued study.

Read the full article
Report a problem with this article

Related articles

  • More for Researchers

    Identifying opioid relapse during COVID-19 using natural language processing of nationwide Veterans Health Administration electronic medical record data

    Abstract: Novel and automated means of opioid use and relapse risk detection are needed. Unstructured electronic medical record data, including written progress notes, can be mined for clinically relevant information, including the presence of substance use and relapse-critical markers of risk and recovery from opioid use disorder (OUD). In this study, we used natural language processing (NLP) to automate the extraction of opioid relapses, and the timing of these occurrences, from veteran patients' electronic medical record. We then demonstrated the utility of our NLP tool via analysis of pre-/post-COVID-19 opioid relapse trends among veterans with OUD. For this demonstration, we analyzed data from 107,606 veterans OUD enrolled in Veterans Health Administration, comparing a pandemic-exposed cohort (n = 53,803; January 2019-March 2021) to a matched prepandemic cohort (n = 53,803; October 2017-December 2019). The recall of our NLP tool was 75% and our precision was 94%, demonstrating moderate sensitivity and excellent specificity. Using the NLP tool, we found that the odds of opioid relapse postpandemic onset were proportionally higher compared to prepandemic trends, despite patients having fewer mental health encounters from which to derive instances of relapse postpandemic onset. In this research application of the tool, and as hypothesized, we found that opioid relapse risk was elevated postpandemic. The application of NLP Methods: to identify and monitor relapse risk holds promise for future surveillance, risk prevention, and clinical outcome research.